Cross-reactive antifungal adoptive T cell therapy

摘要

The present invention provides a method to manufacture panfungal T-cell products with specificity against a range of clinical fungal pathogens by use of the blood and stem cells of healthy donors as the starting material. Specifically, the combination of T cells stimulated by lysates of